Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy

Kidney International

Volumn 81, Issue 11, 2012, Pages 1086-1097

  Yu, Ling ^a   Su, Yan ^a   Paueksakon, Paisit ^a   Cheng, Huifang ^a   Chen, Xiwu ^a   Wang, Hongtao ^a   Harris, Raymond C ^a,b   Zent, Roy ^a,b,c   Pozzi, Ambra ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b Veterans Affairs Hospitals   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akita; Balb c; glomerular filtration rate; nodular glomerulosclerosis; streptozotocin

Indexed keywords

ALPHA1 INTEGRIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; DISEASE SEVERITY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERGLYCEMIA; INSULIN 2 GENE; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MALE; MOLECULAR PATHOLOGY; MOUSE; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 84862826199     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.474     Document Type: Article

References (32)

1. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004; 25: 971-1010. (Pubitemid 39657775)
2. van Dijk C, Berl T. Pathogenesis of diabetic nephropathy. Rev Endocr Metab Disord 2004; 5: 237-248. (Pubitemid 38903581)
3. Brosius 3rd FC, Alpers CE, Bottinger EP et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512.
4. Breyer MD, Bottinger E, Brosius 3rd FC et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 27-45. (Pubitemid 43073154)
5. Tesch GH, Lim AK. Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol 2011; 300: F301-F310.
6. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003; 284: F1138-F1144. (Pubitemid 36578440)
7. Zhao HJ, Wang S, Cheng H et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-2669. (Pubitemid 44484656)
8. Hudkins KL, Pichaiwong W, Wietecha T et al. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 2010; 21: 1533-1542.
9. Kanetsuna Y, Takahashi K, Nagata M et al. Deficiency of endothelial nitricoxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 2007; 170: 1473-1484. (Pubitemid 47339294)
10. Yoshioka M, Kayo T, Ikeda T et al. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997; 46: 887-894. (Pubitemid 27188269)
11. Gurley SB, Clare SE, Snow KP et al. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 2006; 290: F214-F222.
12. Gurley SB, Mach CL, Stegbauer J et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol 2010; 298: F788-F795.
13. Wong DW, Oudit GY, Reich H et al. Loss of angiotensin-converting enzyme- 2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007; 171: 438-451. (Pubitemid 47344677)
14. Kakoki M, Sullivan KA, Backus C et al. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci USA 2010; 107: 10190-10195.
15. Chen X, Moeckel G, Morrow JD et al. Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004; 165: 617-630. (Pubitemid 38971391)
16. Zent R, Yan X, Su Y et al. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. Kidney Int 2006; 70: 460-470. (Pubitemid 44141572)
17. Jerums G, Premaratne E, Panagiotopoulos S et al. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010; 53: 2093-2104.
18. Gardner H, Broberg A, Pozzi A et al. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci 1999; 112(Part 3): 263-272. (Pubitemid 29080649)
19. Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med 2011; 2011: 971524.
20. Holthofer H, Schulte BA, Spicer SS. Expression of binding sites for Dolichos biflorus agglutinin at the apical aspect of collecting duct cells in rat kidney. Cell Tissue Res 1987; 249: 481-485.
21. Breyer MD, Qi Z, Tchekneva EE et al. Insight into the genetics of diabetic nephropathy through the study of mice. Curr Opin Nephrol Hypertens 2008; 17: 82-86. (Pubitemid 350295202)
22. Qi Z, Fujita H, Jin J et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005; 54: 2628-2637. (Pubitemid 41233584)
23. Chen X, Abair TD, Ibanez MR et al. Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation. Mol Cell Biol 2007; 27: 3313-3326. (Pubitemid 46685210)
24. Chen X, Whiting C, Borza C et al. Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression. Mol Cell Biol 2010; 30: 3048-3058.
25. Borza CM, Chen X, Mathew S et al. Integrin {alpha}1{beta}1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. J Biol Chem 2010; 285: 40114-40124.
26. Nakagawa T, Sato W, Glushakova O et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550. (Pubitemid 46193319)
27. Wang CH, Li F, Hiller S et al. A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci USA 2011; 108: 2070-2075.
28. Gardner H, Kreidberg J, Koteliansky V et al. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol 1996; 175: 301-313. (Pubitemid 26160758)
29. Qi Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 2004; 286: F590-F596. (Pubitemid 38233654)
30. Hem A, Smith AJ, Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 1998; 32: 364-368. (Pubitemid 28482470)
31. Yu L, Border WA, Anderson I et al. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int 2004; 66: 1774-1784. (Pubitemid 41094301)
32. Pozzi A, Moberg PE, Miles LA et al. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000; 97: 2202-2207. (Pubitemid 30134046)